BIOCON Intraday Analysis...

BIOCON Share Price

Open 1126.00 Change Price %
High 1132.00 1 Day -21.30 -1.88
Low 1106.15 1 Week 52.70 4.98
Close 1111.40 1 Month 137.60 14.13
Volume 298539 1 Year 639.45 135.49
52 Week High 1138.50
52 Week Low 454.10
BIOCON Important Levels
Resistance 2 1135.36
Resistance 1 1125.49
Pivot 1116.52
Support 1 1097.31
Support 2 1087.44
NSE INDIA Most Active Stocks
JPASSOCIAT 13.90 -3.81%
JINDALSTEL 110.25 0.78%
SUZLON 17.75 2.31%
RELIANCE 1207.50 10.96%
ICICIBANK 286.15 0.47%
UNITECH 5.75 -1.71%
IDEA 112.60 3.92%
UJAAS 37.25 2.62%
RCOM 35.75 1.13%
GMRINFRA 14.95 0.00%
More..
NSE INDIA Top Gainers Stocks
BIRLACOT 0.10 100.00%
JINDWORLD 264.30 20.00%
HOTELRUGBY 4.75 18.75%
ARCOTECH 725.55 15.29%
RUPA 305.10 14.89%
SRGINFOTEC 0.40 14.29%
EUROTEXIND 33.35 12.29%
RIIL 452.85 11.73%
PSL 6.95 11.20%
PSL 6.95 11.20%
More..
NSE INDIA Top Losers Stocks
VKSPL 0.10 -33.33%
FARMAXIND 0.10 -33.33%
RASOYPR 0.15 -25.00%
TRICOM 0.90 -14.29%
BLUECHIP 0.30 -14.29%
AUSTRAL 0.30 -14.29%
MVL 0.50 -9.09%
MVL 0.50 -9.09%
TARMAT 54.10 -8.77%
XLENERGY 2.75 -8.33%
More..

Biocon Limited (NSE: BIOCON)

BIOCON Technical Analysis 5
As on 22nd Feb 2017 BIOCON Share Price closed @ 1111.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 824.22 & Strong Buy for SHORT-TERM with Stoploss of 1001.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
BIOCON Target for February
1st Target up-side 1077.71
2nd Target up-side 1124.51
3rd Target up-side 1171.3
1st Target down-side 944.19
2nd Target down-side 897.39
3rd Target down-side 850.6
BIOCON Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
BIOCON Other Details
Segment EQ
Market Capital 20400484352.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.biocon.com
BIOCON Address
BIOCON
20th KM, Hosur Road
Electronics City
Bengaluru, 560100
India
Phone: 91 80 2808 2808
Fax: 91 80 2852 3423
BIOCON Latest News
Interactive Technical Analysis Chart Biocon Limited ( BIOCON NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Biocon Limited
BIOCON Business Profile
Biocon is in the Pharmaceuticals sector. Biocon, Syngene and Clinigene together employ approximately 4,500 personnel including biologists, chemists, medical practitioners, pharmacologists, engineers, finance/legal/marketing analysts, HR generalists and general administrators. Around 6% of its employees have PhD degrees, 45% have a master’s degree, and 33% are graduates. Biocon also collaborates with educational institutes to make courses more industry oriented. The current market capitalisation stands at Rs 7,437.00 crore.The company has reported a consolidated sales of Rs 740.81 crore and a Net Profit of Rs 105.27 crore for the quarter ended Sep 2013. The company management includes John Shaw - Vice Chairman, Bala S Manian - Director, Charles L Cooney - Director, Mary Harney - Director, Ravi Mazumdar - Director, Russell Walls - Director, Daniel M Bradbury - Additional Director. It is listed on the BSE with a BSE Code of 532523 and the NSE with an NSE Code of BIOCON. Its Registered office is at 20th K M, Hosur Road, Electronic City P O, Bangalore,Karnataka - 560100.